Shares of BG Medicine, Inc. (OTCMKTS:BGMD – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. BG Medicine shares last traded at $0.00, with a volume of 11,820 shares changing hands.
BG Medicine Price Performance
About BG Medicine
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Recommended Stories
- Five stocks we like better than BG Medicine
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- What is Short Interest? How to Use It
- Why Call Option Traders Are Targeting This Dividend ETF Now
- P/E Ratio Calculation: How to Assess Stocks
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
